It presents iVascular to 400 professionals in the medical sector in the glass gallery of the Cibeles Palace in Madrid.

iVascular, clear Spanish accent and with an international vocation, bet for specialization as a generator element of knowledge and high value-added technologies capable of improving the lives of patients. Lluis Duocastella, CEO of iVascular, remarked during the event that is a project specific and focused in the cardiovascular area. Our initial and future focus constitute devices and therapies of direct application to the fields of Cardiology, peripheral vascular and Neurology. want to be specialists in each of these fields. ”

Ignacio Vega (above left) Lluís Duocastella (above Center) Raul Diez Varela (bottom center)

also wanted to emphasize the importance of technology and innovation within iVascular: want to create and develop products or technologies of high value added through of the Vertical technology integration ”integrating all processes of production using its own technology. In this sense, iVascular is open to develop the ideas of other doctors via different collaboration frameworks, thereby creating a Bank of ideas in the pursuit of innovation ”.

For his part, Ignacio Vega, President of iVascular, wanted to underline the value of the partners in this project during his presentation, five companies that provide more than 1,160 million turnover, which are present in 96 countries and have more than 2,800 workers. With this group started the adventure of manufacture in Spain, a large enough group to develop a line of current vascular products and to encourage research and development of future innovative products, providing us a place of reference in the world of healthcare industry, which is where we needed to beknowledge and development of the country. ”

during the event, guests were able to enjoy as well as a fun musical spectacle that enliven the presentation of the company.

IVascular about

iVascular is a company focused on the design and manufacture of devices and implants in the cardiovascular area, with high technological and innovative component. Partners who integrate this company are Spanish companies Life Vascular Devices, Cardiva, Kern Pharma, and Ames, along with the Canadian Polytech,

the initial investment has been more than 13 M€, intended for starting to point its facilities in Sant Vicenç dels Horts (Barcelona), with latest generation machinery and to the recruitment of a team of specialists of proven experience and qualificationon in the fields of Biochemistry, engineering, biology and medicine.

In addition to financial solvency, the founding partners of iVascular bring projection to it, because they added a total of 2,800 employees and a global turnover of 1,160 M€; still present in 96 countries.

In order to convert iVascular into a reference national and international its strategy is based on the Vertical technology integration, i.e., owns the entire technological process, allowing you to develop, innovate and produce cardiovascular devices from raw materials (plastics, polymers, metals, etc.) to devices and implants late.

iVascular is a company with a vocation for global market. For this purpose it has not only built a factory in Catalonia, but also in Brazil, counting on the support and direct collaboration of Kern Pharma. With this iVascular strategy you expected to be implanted in the majority of countries at the end of 2017.

The company has a technology center of 1000m2 in white rooms (ISO 7 and ISO 8) and 250 m 2 of r & d laboratories also collaborates with research institutes and universities such as CSIC (Institute of science and technology of polymers), FISLEON (Health Research Foundation in León)ENSCP (Ecole Nationales Supérieure de Chimie de Paris) and Université Laval (Department of Mining, Metallurgy and Materials Engineering in Quebec, Canada); Since the DNA of iVascular is collaboration with other entities of reference as a formula to be at the technological forefront.